Louisiana 2018 Regular Session

Louisiana House Bill HB720

Introduced
3/21/18  

Caption

Provides relative to liberative prescription

Impact

The adoption of HB 720 is anticipated to significantly influence how insurance claims are processed in Louisiana. By extending the liberative prescription period to ten years, the law offers more protection to policyholders who suffer from malpractice by insurance companies. Current regulations mandate insurers to pay claims within 30 days of receiving satisfactory proof, but the bill's change could lead to a greater emphasis on insurers fulfilling their obligations promptly to avoid potential liability over more extended timeframes, ultimately enhancing consumer confidence in the insurance process.

Summary

House Bill 720 seeks to amend the Louisiana Revised Statutes by establishing a ten-year liberative prescriptive period for specific acts of bad faith related to the payment of insurance claims. This legislation outlines that the prescriptive period begins at the time of each bad faith act, ensuring that insured individuals have a considerable timeframe to bring forth claims against insurers who may neglect their duties. The bill aims to strengthen accountability among insurers in their dealings and prompt more timely settlements of claims, which is critical for individuals relying on these payments.

Sentiment

Discussion around HB 720 has generated mixed sentiments within both legislative and community circles. Supporters argue that this legislation fosters fairness by holding insurance companies accountable for bad faith actions that might otherwise go unchallenged due to shorter statutes of limitations. Critics, however, warn that extending the period could lead to increased litigation and administrative burdens on insurers, potentially affecting the cost of insurance premiums. This divide highlights a broader concern about balancing consumer protection with business interests in the insurance sector.

Contention

One notable point of contention is the potential for the law to generate more lawsuits against insurers, which could lead to higher operational costs for these companies. Critics claim that while it aims to provide justice for consumers, it could inadvertently make the state less attractive for insurance businesses due to heightened risks of litigation. Furthermore, the retroactive application of this law may lead to unforeseen consequences, such as a surge in claims from past incidents that otherwise might have been settled or dismissed under previous laws.

Companion Bills

No companion bills found.

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.